Similarly, there are reports indicating that abnormal activation of the STING-IRF3 pathway facilitates hepatocyte apoptosis and disrupts glucose and lipid metabolism, resulting in the development of NAFLD (66). The gene discussed is STING1; the disease is metabolic dysfunction-associated steatotic liver disease.